Skip to main content

Parkinsonism

  • Chapter
  • First Online:
Neurology
  • 3220 Accesses

Abstract

Parkinsonism is seen in patients with disease of the extrapyramidal system. The key components of parkinsonism are rigidity and bradykinesia. The presence of tremor, asymmetry, cognitive decline, cerebellar abnormalities, and autonomic dysfunction helps to define the cause. Parkinson disease (PD) is the most common of the parkinsonian syndrome, and is defined by asymmetric resting tremor, bradykinesia, and rigidity. Patients with PD respond to levodopa in the early stages of the disease, but become less responsive and develop more drug-related side effects and disability as the disease progresses. Progressive supranuclear palsy usually presents with gait difficulty, and the key diagnostic clue is difficulty with downward saccadic eye movements. Multiple system atrophy may include cerebellar and autonomic features that overshadow the extrapyramidal ones. Corticobasal degeneration is an extrapyramidal disorder with cognitive and behavioral abnormalities including prominent limb apraxia. Parkinsonism may be related to drugs (particularly neuroleptic agents) or cerebrovascular disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Aarsland D, Zaccai J, Brayne C. A systematic review of prevalence studies of dementia in Parkinson’s disease. Mov Disord. 2006;20:1255–63.

    Article  Google Scholar 

  • Ahlskog JE, Uitti RJ. Rasagiline, Parkinson neuroprotection, and delayed-start trials: still no satisfaction? Neurology. 2010;74:1143–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • de la Fuente-Fernandez R. Role of DaTSCAN and clinical diagnosis in Parkinson disease. Neurology. 2012;78:696–701.

    Article  PubMed  Google Scholar 

  • Faber R, Trimble MR. Electroconvulsive therapy in Parkinson’s disease and other movement disorders. Mov Disord. 1991;6:293–303.

    Article  CAS  PubMed  Google Scholar 

  • Ghika J, Bogousslavsky J. Abnormal movements. In: Bogousslavsky J, Caplan L, editors. Stroke syndromes. Cambridge: Cambridge University Press; 2001. p. 162–81.

    Chapter  Google Scholar 

  • Hardie RJ, Lees AJ. Neuroleptic-induced Parkinson’s syndrome: clinical features and results of treatment with levodopa. J Neurol Neurosurg Psychiatry. 1988;51:850–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hardy J, Cai H, Cookson MR, Gwinn-Hardy K, Singleton A. Genetics of Parkinson’s disease and parkinsonism. Ann Neurol. 2006;60:389–98.

    Article  CAS  PubMed  Google Scholar 

  • Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ. What features improve the accuracy of clinical diagnosis in Parkinson’s disease: a clinicopathologic study. Neurology. 1992;42:1142–6.

    Article  CAS  PubMed  Google Scholar 

  • Jankovic J, Schwartz J, Vander Linden C. Comparison of sinemet CR4 and standard sinemet: double blind and long-term open trial in parkinsonian patients with motor fluctuations. Mov Disord. 1989;4:303–9.

    Article  CAS  PubMed  Google Scholar 

  • Kato N, Arai K, Hattori T. Study of the rostral midbrain atrophy in progressive supranuclear palsy. J Neurol Sci. 2003;15:57–60.

    Article  Google Scholar 

  • Kleiner-Fisman G, Herzog J, Fisman DN, et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord. 2006;21:S290–304.

    Article  PubMed  Google Scholar 

  • Mayeux R, Stern Y, Rosen J, Leventhal J. Depression, intellectual impairment, and Parkinson disease. Neurology. 1981;31:645–50.

    Article  CAS  PubMed  Google Scholar 

  • Miyasaki JM, Shannon K, Voon V, et al. Practice parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review). Neurology. 2006;66:996–1002.

    Article  CAS  PubMed  Google Scholar 

  • Nath U, Ben-Shlomo Y, Thomson RG, Lees AJ, Burn DJ. Clinical features and natural history of progressive supranuclear palsy. A clinical cohort study. Neurology. 2003;60:910–6.

    Article  CAS  PubMed  Google Scholar 

  • Pinto S, Ozsancak C, Tripoliti E, et al. Treatments for dysarthria in Parkinson’s disease. Lancet Neurol. 2004;3:547–56.

    Article  PubMed  Google Scholar 

  • Pondal M, Marras C, Miyasaki J, et al. Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic. J Neurol Neurosurg Psychiatry. 2013;84:130–5.

    Article  PubMed  Google Scholar 

  • Schrag A, Ben-Shlomo Y, Brown R, Marsden CD, Quinn N. Young-onset Parkinson’s disease revisited—clinical features, natural history, and mortality. Mov Disord. 1998;13:885–94.

    Article  CAS  PubMed  Google Scholar 

  • Wenning GK, Litvan I, Jankovic J, et al. Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination. J Neurol Neurosurg Psychiatry. 1998;64:184–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wenning GK, Colosimo C, Geser F, Poewe W. Multiple system atrophy. Lancet Neurol. 2004;3:93–103.

    Article  PubMed  Google Scholar 

  • Winge K, Rasmussen D, Werdelin LM. Constipation in neurological diseases. J Neurol Neurosurg Psychiatry. 2003;74:13–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Winikates J, Jankovic J. Clinical correlates of vascular parkinsonism. Arch Neurol. 1999;56:98–102.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Tarulli, A. (2016). Parkinsonism. In: Neurology. Springer, Cham. https://doi.org/10.1007/978-3-319-29632-6_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-29632-6_13

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-29630-2

  • Online ISBN: 978-3-319-29632-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics